Maternal obesity increases oxidative stress in the newborn

Obesity

Volumn 23, Issue 8, 2015, Pages 1650-1654

  Gallardo, Juan Manuel ^a   Gõmez Lõpez, Jaqueline ^b,c   Medina Bravo, Patricia ^d   Juárez Sánchez, Francisco ^a   Contreras Ramos, Alejandra ^d   Galicia Esquivel, Matilde ^d   Sánchez Urbina, Rocío ^d   Klünder Klünder, Miguel ^d  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b Hospital de la Mujer   (Mexico)

^c INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^d HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

MALONALDEHYDE; NITRIC OXIDE;

ADULT; ARTICLE; BLOOD LEVEL; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL OBESITY; NEWBORN; OXIDATIVE STRESS; PROGENY; COMPLICATION; GENETICS; MOTHER; OBESITY; PREGNANCY; RISK FACTOR; YOUNG ADULT;

ADULT; BODY MASS INDEX; FEMALE; HUMANS; INFANT, NEWBORN; MOTHERS; OBESITY; OVERWEIGHT; OXIDATIVE STRESS; PREGNANCY; RISK FACTORS; YOUNG ADULT;

EID: 84937510252     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.21159     Document Type: Article

References (37)

1. Dabelea D, Harrod CS,. Role of developmental overnutrition in pediatric obesity and type 2 diabetes. Nutr Rev 2013; 71 (Suppl 1): S62-67.
2. Lawlor DA, Smith GD, O'Callaghan M, et al., Epidemiologic evidence for the fetal overnutrition hypothesis: findings from the mater-university study of pregnancy and its outcomes. Am J Epidemiol 2007; 165: 418-42 4.
3. Patro B, Liber A, Zalewski B, Poston L, Szajewska H, Koletzko B,. Maternal and paternal body mass index and offspring obesity: a systematic review. Ann Nutr Metab 2013; 63: 32-41.
4. Malti N, Merzouk H, Merzouk SA, et al., Oxidative stress and maternal obesity: Feto-placental unit interaction. Placenta 2014; 35: 411-416.
5. Catalano PM, Presley L, Minium J, Hauguel-de Mouzon S,. Fetuses of obese mothers develop insulin resistance in utero. Diabetes Care 2009; 32: 1076-1080.
6. Thompson LP, Al-Hasan Y,. Impact of oxidative stress in fetal programming. J Pregnancy 2012; 2012: 582748
7. Lucas A,. Programming by early nutrition: an experimental approach. J Nutr 1998; 128: 401S-406S.
8. Dennery PA,. Effects of oxidative stress on embryonic development. Birth Defects Res C Embryo Today 2007; 81: 155-162.
9. Haffner SM,. Relationship of metabolic risk factors and development of cardiovascular disease and diabetes. Obesity (Silver Spring) 2006; 14(Suppl3): 121S-127S.
10. Wellen KE, Hotamisligil GS,. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 2003; 112: 1785-1788.
11. Berg AH, Scherer PE,. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 2005; 96: 939-949.
12. Saben J, Lindsey F, Zhong Y, et al., Maternal obesity is associated with a lipotoxic placental environment. Placenta 2014; 35: 171-177.
13. Hracsko Z, Orvos H, Novak Z, Pal A, Varga IS,. Evaluation of oxidative stress markers in neonates with intra-uterine growth retardation. Redox Rep 2008; 13: 11-16.
14. Robles R, Palomino N, Robles A,. Oxidative stress in the neonate. Early Hum Dev 2001; 65 (Suppl2): S75-S81.
15. Shaker OG, Sadik NA,. Pathogenesis of preeclampsia: implications of apoptotic markers and oxidative stress. Hum Exp Toxicol 2013; 32: 1170-1178.
16. Olusi SO,. Obesity is an independent risk factor for plasma lipid peroxidation and depletion of erythrocyte cytoprotectic enzymes in humans. Int J Obes Relat Metab Disord 2002; 26: 1159-1164.
17. Elizalde M, Ryden M, van Harmelen V, et al., Expression of nitric oxide synthases in subcutaneous adipose tissue of nonobese and obese humans. J Lipid Res 2000; 41: 1244-1251.
18. Del Rio D, Stewart AJ, Pellegrini N,. A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovasc Dis 2005; 15: 316-328.
19. Huang PL,. eNOS, metabolic syndrome and cardiovascular disease. Trends Endocrinol Metab 2009; 20: 295-302.
20. Isik B, Ceylan A, Isik R,. Oxidative stress in smokers and non-smokers. Inhal Toxicol 2007; 19: 767-769.
21. Das SK, Vasudevan DM,. Alcohol-induced oxidative stress. Life Sci 2007; 81: 177-187.
22. Ornoy A,. Embryonic oxidative stress as a mechanism of teratogenesis with special emphasis on diabetic embryopathy. Reprod Toxicol 2007; 24: 31-41.
23. Maritim AC, Sanders RA, Watkins JB,. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 2003; 17: 24-38.
24. Wade CR, van Rij AM,. Plasma thiobarbituric acid reactivity: reaction conditions and the role of iron, antioxidants and lipid peroxy radicals on the quantitation of plasma lipid peroxides. Life Sci 1988; 43: 1085-1093.
25. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR,. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 1982; 126: 131-138.
26. Cuzick J,. A Wilcoxon-type test for trend. Stat Med 1985; 4: 87-90.
27. Salsberry PJ, Reagan PB,. Taking the long view: the prenatal environment and early adolescent overweight. Res Nurs Health 2007; 30: 297-307.
28. Loy SL, Sirajudeen KN, Hamid Jan JM,. The effects of prenatal oxidative stress levels on infant adiposity development during the first year of life. J Dev Orig Health Dis 2014; 5: 142-151.
29. Ylä-Herttuala S, Palinski W, Rosenfeld ME, et al., Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest 1989; 84: 1086-1095.
30. Slatter DA, Bolton CH, Bailey AJ,. The importance of lipid-derived malondialdehyde in diabetes mellitus. Diabetologia 2000; 43: 550-557.
31. Meuwese MC, Stroes ES, Hazen SL, et al., Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-norfolk prospective population study. J Am Coll Cardiol 2007; 50: 159-165.
32. Baldus S, Heeschen C, Meinertz T, et al., Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 2003; 108: 1440-1445.
33. Myatt L,. Review: Reactive oxygen and nitrogen species and functional adaptation of the placenta. Placenta 2010; 31(Suppl): S66-S69.
34. Turgut M, Başaran O, Cekmen M, Karataş F, Kurt A, Aygün AD., Oxidant and antioxidant levels in preterm newborns with idiopathic hyperbilirubinaemia. J Paediatr Child Health 2004; 40: 633-637.
35. Qanungo S, Mukherjea M,. Ontogenic profile of some antioxidants and lipid peroxidation in human placental and fetal tissues. Mol Cell Biochem 2000; 215: 11-19.
36. Heerwagen MJ, Miller MR, Barbour LA, Friedman JE,. Maternal obesity and fetal metabolic programming: a fertile epigenetic soil. Am J Physiol Regul Integr Comp Physiol 2010; 299: R711-R722.
37. England LJ, Levine RJ, Qian C, et al., Smoking before pregnancy and risk of gestational hypertension and preeclampsia. Am J Obstet Gynecol 2002; 186: 1035-1040.